Stroke, hemiplegia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients will eligible for inclusion in the trial if they will aged at least 18 years and had USN after ischemic stroke diagnosis within six months of the start of stroke symptoms (subacute phase). Ischemic stroke will be confirm using computed tomography (CT) or magnetic resonance imaging (MRI), and USN will objectively diagnosed using conventional Behavior Inattention Tasks (BIT-C) with a cutoff value of <129.
Exclusion criteria
Exclusion criteria: Individuals will excluded if they will suffer hemorrhagic stroke, metal-in-cranium injuries near the electrode placement area, intracerebral vascular clips or any other electrically sensitive support system, clinical instability, epilepsy, severe cognitive impairment, bilateral lesions, global aphasia, previous visual disturbances, pregnancy, or other neurological diseases.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Decrease the degree of unilateral spatial neglect after treatment verified by Behavior Inattention Test (BIT), from finding a variation of at least 15% in the pre and post intervention measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| Decrease the degree of unilateral spatial neglect after treatment verified by Catherine Bergego scale, from finding a variation of at least 15% in the pre and post intervention measurements;Increasing the degree of autonomy observed with the Barthel indez, from the finding of a change of at least 15% in pre and post intervention measurements.;Increasing the degree of quality of life observed with the European (5D) Quality of life Scale, from the finding of a change of at least 15% in pre and post intervention measurements.;Decrease of stroke severity observed with the National Institutes of Health Stroke Scale (NIHSS), from the finding of a change of at least 15% in pre and post intervention measurements.;Increasing the degree of functional impairment observed with the Functional Independence Measure (FIM), from the finding of a change of at least 15% in pre and post intervention measurements. | — |
Countries
Brazil
Contacts
Hospital das Clínicas da Faculdade de Medicina de Botucatu